- Healthcare was the second-best performing sector in China in 2020.
- The immediate healthcare needs stemming from the pandemic, together with the emergence of green shoots in biotech innovation, paved the way for a landmark year in the development of China’s healthcare system.
- While we believe pharmaceuticals, particularly biotechnology, present the greatest upside potential, all of China’s health care sub-industries enjoyed a year of growth and positive change.
- The COVID-19 pandemic exposed gaps in China’s health care infrastructure that the government is determined to bridge, which may lead to a long-term increase in public spending on health care.
For further details see:
China Healthcare: A Rediscovered Sector Keeps Its Momentum